• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION PROMUS PREMIER; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION PROMUS PREMIER; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number 9552
Device Problem Difficult to Advance (2920)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 07/21/2020
Event Type  malfunction  
Manufacturer Narrative
Initial reporter facility name - (b)(6).Device evaluated by mfr.: promus premier ous mr 28 x 4.00 stent delivery system was returned for analysis.A visual examination of the stent found stent damage.Mid- struts were noted to be lifted.The undamaged stent outer diameter was measured and the result was within maximum crimped stent profile.The balloon was reviewed, and no issues were noted.The balloon wings were tightly wrapped and evenly folded and were not subjected to positive pressure.A visual and tactile examination of the hypotube found multiple kinks.A visual and tactile examination of the shaft polymer extrusion found no issues.An examination (visual and via scope) found damage.Device tracked without issues on a 0.0140 inch test guidewire.No other issues were identified during the product analysis.
 
Event Description
Reportable based on device analysis completed on 15sep2020.It was reported that advancing difficulties were encountered.The 90% stenosed target lesion with unstable plaques was located in the severely tortuous proximal end of the left anterior descending artery (lad) and 80% stenosis in the mid lad.After predilatation was performed with a 2.5 x 15 balloon catheter, a 3.5 x 28 stent was placed.Subsequently, a 28 x 4.00 promus premier drug-eluting stent was advanced in the proximal lad.However, the device met great resistance due to severe tortuousity.Physician attempted several times but eventually retrieved the device.The procedure was completed with another of the same device.There were no patient complications reported and the patient status was stable.However, returned device analysis revealed stent damage.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS PREMIER
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key10626861
MDR Text Key209793673
Report Number2134265-2020-13012
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Reporter Occupation Physician
Type of Report Initial
Report Date 10/05/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/05/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/24/2020
Device Model Number9552
Device Catalogue Number9552
Device Lot Number0022458974
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/25/2020
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/15/2020
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/25/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age69 YR
Patient Weight51
-
-